Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies

被引：30

作者：

Ochoa, Sebastian ^{[1
]}

Ding, Li ^{[1
]}

Kreuzburg, Samantha ^{[1
]}

Treat, Jennifer ^{[2
]}

Holland, Steven M. ^{[1
]}

Zerbe, Christa S. ^{[1
]}

机构：

[1] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, Bethesda, MD 20892 USA

[2] Med Sci & Comp, Rockville, MD USA

来源：

CLINICAL INFECTIOUS DISEASES | 2021年 / 72卷 / 12期

基金：

美国国家卫生研究院;

关键词：

daratumumab; mycobacteria; disseminated; interferon gamma; autoantibodies;

D O I：

10.1093/cid/ciaa1086

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Patients with autoantibodies to interferon-gamma (IFN-gamma) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-gamma who had progressive infection, resulting in clinical and radiographic improvement.

引用

页码：2206 / 2208

页数：3

共 50 条

[21] Daratumumab (anti-CD38) Induces Loss of CD38 on Red Blood Cells
Sullivan, H. C.
Gerner-Schmidt, C.
Thompson, L.
Jacob, R.
Dean, C.
Yee, M.
Fasano, R.
Lonial, S.
Kaufman, R. M.
Stowell, S. R.
TRANSFUSION, 2016, 56 : 25A - 26A
[22] Anti-interferon-γ autoantibody in a patient with disseminated Mycobacterium avium complex
Koya, Toshiyuki
Tsubata, Chikako
Kagamu, Hiroshi
Koyama, Ken-ichi
Hayashi, Masachika
Kuwabara, Katsuhiro
Itoh, Takui
Tanabe, Yoshinari
Takada, Toshinori
Gejyo, Fumitake
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (02) : 118 - 122
[23] Autoimmune Nontuberculous Mycobacterial Disease: Characteristic Phenotypes Of Cases With Anti-Interferon-γ Neutralizing Autoantibodies
Aoki, A.
Sakagami, T.
Yoshizawa, K.
Shima, K.
Aoki, N.
Moro, H.
Tanabe, Y.
Koya, T.
Hasegawa, T.
Kikuchi, T.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[24] Efficacy of anti-CD38 Treatment with Daratumumab in Two Cases of Refractory and Severe Sjogren Disease
Nocturne, Gaetane
di Filippo, Mathilde
Marmontel, Oriane
Chretien, Pascale
Krzysiek, Roman
Lifermann, Francois
Rahal, Nawal
Belkhir, Rakiba
Moulin, Philippe
Mariette, Xavier
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4325 - 4326
[25] Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab
Thirkettle, Sally
Russell, Joanne
Wilson, Sarah
Ganijee, Tasneem
Kulkarni, Samar
Cavet, Jim
Monaghan, Phillip J.
ANNALS OF CLINICAL BIOCHEMISTRY, 2020, 57 (02) : 178 - 181
[26] Could anti-CD38 (daratumumab) be used in the management of severe allergic diseases?
Blankestijn, M. A.
Van de Donk, N. W.
Sasser, K.
Knulst, A. C.
Otten, H. G.
ALLERGY, 2017, 72 : 322 - 322
[27] Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies
Tanimizu, Masakuni
Mizuno, Kenji
Hashimoto, Masayuki
ACTA MEDICA OKAYAMA, 2017, 71 (06) : 547 - 552
[28] The First US Domestic Report of Disseminated Mycobacterium avium Complex and Anti-Interferon-γ Autoantibodies
O'Connell, Elise
Rosen, Lindsey B.
LaRue, Richard W.
Fabre, Valeria
Melia, Michael T.
Auwaerter, Paul G.
Holland, Steven M.
Browne, Sarah K.
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (08) : 928 - 932
[29] The First US Domestic Report of Disseminated Mycobacterium avium Complex and Anti-Interferon-γ Autoantibodies
Elise O’Connell
Lindsey B. Rosen
Richard W. LaRue
Valeria Fabre
Michael T. Melia
Paul G. Auwaerter
Steven M. Holland
Sarah K. Browne
Journal of Clinical Immunology, 2014, 34 : 928 - 932
[30] Disseminated non-tuberculous mycobacterial infection caused by anti-interferon-γ autoantibodies in a patient of very advanced age
Yamada, Tomoko
Iwakami, Shin-ichiro
Hara, Sumiko Abe Munechika
Iwakami, Naoko
Nakamura, Ai
Suzuki, Yoshifumi
Sasaki, Shin-ichi
Takahashi, Kazuhisa
GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (07) : 1132 - 1133

← 1 2 3 4 5 →